These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1051 related articles for article (PubMed ID: 25908010)
1. Morbidity and mortality after surgery for cancer of the oesophagus and gastro-oesophageal junction: A randomized clinical trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation. Klevebro F; Johnsen G; Johnson E; Viste A; Myrnäs T; Szabo E; Jacobsen AB; Friesland S; Tsai JA; Persson S; Lindblad M; Lundell L; Nilsson M Eur J Surg Oncol; 2015 Jul; 41(7):920-6. PubMed ID: 25908010 [TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. Klevebro F; Alexandersson von Döbeln G; Wang N; Johnsen G; Jacobsen AB; Friesland S; Hatlevoll I; Glenjen NI; Lind P; Tsai JA; Lundell L; Nilsson M Ann Oncol; 2016 Apr; 27(4):660-7. PubMed ID: 26782957 [TBL] [Abstract][Full Text] [Related]
3. Morbidity and Mortality of Patients Who Underwent Minimally Invasive Esophagectomy After Neoadjuvant Chemoradiotherapy vs Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial. Wang H; Tang H; Fang Y; Tan L; Yin J; Shen Y; Zeng Z; Zhu J; Hou Y; Du M; Jiao J; Jiang H; Gong L; Li Z; Liu J; Xie D; Li W; Lian C; Zhao Q; Chen C; Zheng B; Liao Y; Li K; Li H; Wu H; Dai L; Chen KN JAMA Surg; 2021 May; 156(5):444-451. PubMed ID: 33729467 [TBL] [Abstract][Full Text] [Related]
4. Impact of neoadjuvant chemotherapy and chemoradiotherapy on postoperative cardiopulmonary complications in patients with esophageal cancer. Zhang Z; Zhang H Dis Esophagus; 2017 Apr; 30(4):1-7. PubMed ID: 28375486 [TBL] [Abstract][Full Text] [Related]
5. "Sentinel lymph node imaging with sequential SPECT/CT lymphoscintigraphy before and after neoadjuvant chemoradiotherapy in patients with cancer of the oesophagus or gastro-oesophageal junction - a pilot study". Gabrielson S; Tsai JA; Celebioglu F; Nilsson M; Rouvelas I; Lindblad M; Bjäreback A; Tomson A; Axelsson R Cancer Imaging; 2018 Dec; 18(1):53. PubMed ID: 30563571 [TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial. von Döbeln GA; Klevebro F; Jacobsen AB; Johannessen HO; Nielsen NH; Johnsen G; Hatlevoll I; Glenjen NI; Friesland S; Lundell L; Yu J; Nilsson M Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30137281 [TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Shapiro J; van Lanschot JJB; Hulshof MCCM; van Hagen P; van Berge Henegouwen MI; Wijnhoven BPL; van Laarhoven HWM; Nieuwenhuijzen GAP; Hospers GAP; Bonenkamp JJ; Cuesta MA; Blaisse RJB; Busch ORC; Ten Kate FJW; Creemers GM; Punt CJA; Plukker JTM; Verheul HMW; Bilgen EJS; van Dekken H; van der Sangen MJC; Rozema T; Biermann K; Beukema JC; Piet AHM; van Rij CM; Reinders JG; Tilanus HW; Steyerberg EW; van der Gaast A; Lancet Oncol; 2015 Sep; 16(9):1090-1098. PubMed ID: 26254683 [TBL] [Abstract][Full Text] [Related]
8. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial]. Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918 [No Abstract] [Full Text] [Related]
9. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis. Li J; Zhao Q; Ge X; Song Y; Tian Y; Wang S; Liu M; Qiao X BMC Surg; 2021 Mar; 21(1):137. PubMed ID: 33731072 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy. Lagarde SM; Navidi M; Gisbertz SS; van Laarhoven HW; Sumpter K; Meijer SL; Disep B; Immanuel A; Griffin SM; van Berge Henegouwen MI Br J Surg; 2016 Nov; 103(12):1658-1664. PubMed ID: 27696382 [TBL] [Abstract][Full Text] [Related]
11. Outcome of neoadjuvant therapies for cancer of the oesophagus or gastro-oesophageal junction based on a national data registry. Klevebro F; Lindblad M; Johansson J; Lundell L; Nilsson M Br J Surg; 2016 Dec; 103(13):1864-1873. PubMed ID: 27689845 [TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in a randomized trial of neoadjuvant chemotherapy or chemoradiotherapy plus surgery in patients with oesophageal cancer (NeoRes trial). Sunde B; Klevebro F; Johar A; Johnsen G; Jacobsen AB; Glenjen NI; Friesland S; Lindblad M; Ajengui A; Lundell L; Lagergren P; Nilsson M Br J Surg; 2019 Oct; 106(11):1452-1463. PubMed ID: 31436322 [TBL] [Abstract][Full Text] [Related]
13. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients. Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235 [TBL] [Abstract][Full Text] [Related]
14. Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma. Vos EL; Carr RA; Hsu M; Nakauchi M; Nobel T; Russo A; Barbetta A; Tan KS; Tang L; Ilson D; Ku GY; Wu AJ; Janjigian YY; Yoon SS; Bains MS; Jones DR; Coit D; Molena D; Strong VE Br J Surg; 2021 Nov; 108(11):1332-1340. PubMed ID: 34476473 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemoradiation for locally advanced resectable carcinoma of the esophagus: A single-center experience from India with a brief review of the literature. Krishnamurthy A; Mohanraj N; Radhakrishnan V; John A; Selvaluxmy G Indian J Cancer; 2017; 54(4):646-651. PubMed ID: 30082551 [TBL] [Abstract][Full Text] [Related]
16. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction. Epari K; Cade R ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710 [TBL] [Abstract][Full Text] [Related]
17. Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival. Goense L; van der Sluis PC; van Rossum PSN; van der Horst S; Meijer GJ; Haj Mohammad N; van Vulpen M; Mook S; Ruurda JP; van Hillegersberg R J Surg Oncol; 2017 Jun; 115(7):812-820. PubMed ID: 28267212 [TBL] [Abstract][Full Text] [Related]
18. Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study. van der Werf LR; Dikken JL; van der Willik EM; van Berge Henegouwen MI; Nieuwenhuijzen GAP; Wijnhoven BPL; Eur J Cancer; 2018 Mar; 91():76-85. PubMed ID: 29353163 [TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience. Chen Y; Hao D; Wu X; Xing W; Yang Y; He C; Wang W; Liu J; Wang J Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475725 [TBL] [Abstract][Full Text] [Related]
20. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm. Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]